Tianjin Lisheng PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Tianjin Lisheng PharmaceuticalLtd has a total shareholder equity of CN¥4.9B and total debt of CN¥60.9M, which brings its debt-to-equity ratio to 1.2%. Its total assets and total liabilities are CN¥6.1B and CN¥1.1B respectively. Tianjin Lisheng PharmaceuticalLtd's EBIT is CN¥114.3M making its interest coverage ratio -1.3. It has cash and short-term investments of CN¥2.1B.
Key information
1.2%
Debt to equity ratio
CN¥60.89m
Debt
| Interest coverage ratio | -1.3x |
| Cash | CN¥2.10b |
| Equity | CN¥4.93b |
| Total liabilities | CN¥1.12b |
| Total assets | CN¥6.05b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002393's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥856.1M).
Long Term Liabilities: 002393's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥260.9M).
Debt to Equity History and Analysis
Debt Level: 002393 has more cash than its total debt.
Reducing Debt: 002393's debt to equity ratio has reduced from 1.3% to 1.2% over the past 5 years.
Debt Coverage: 002393's debt is well covered by operating cash flow (268.5%).
Interest Coverage: 002393 earns more interest than it pays, so coverage of interest payments is not a concern.